Browsing Tag
London Stock Exchange
330 posts
$ALRT in focus: Oracle cloud deal caps rapid-fire month for Defence Holdings as shares consolidate after MoD spike
Oracle joins Defence Holdings' accelerator weeks after a proposed MoD contract surfaced. What the rapid-fire ALRT news flow means. Read the full analysis.
GSK Nuvalent acquisition puts $GSK in focus as $10.6bn oncology bet reshapes lung cancer pipeline
GSK is buying Nuvalent for USD 10.6bn to expand in lung cancer. Find out what the $GSK oncology deal means for investors.
$MPAC faces margin reset as Mpac Group sells Lambert and warns on customer delays
Mpac Group warned on FY26 profit and sold Lambert for up to ÂŁ20m. Find out what the $MPAC reset means for investors.
Tate & Lyle is leaving London after 87 years, but is the Ingredion premium enough?
Tate & Lyle agreed a £2.7bn Ingredion takeover. Find out what the $TATE deal means for investors and London’s market.
Time Out Group signs first Market franchise as $TMO investors assess India expansion strategy
Time Out Group signed its first Market franchise for Delhi. Find out how the $TMO deal could reshape its capital-light expansion plan.
NewRiver REIT results put $NRR in focus as retail property income and dividend growth recover
NewRiver REIT raised its dividend after stronger FY26 UFFO. Find out what the $NRR retail property recovery means next.
Could Ingredion’s Tate & Lyle deal reshape the global specialty ingredients market?
Find out how Ingredion’s Tate & Lyle deal could reshape specialty ingredients, sugar reduction, and INGR stock sentiment.
Gooch & Housego has a record order book, but can $GHH convert photonics demand into stronger margins?
Gooch & Housego reported higher revenue and a record ÂŁ167.3m order book. Find out what $GHH investors should watch next.
Chemring Group (LSE: CHG) holds FY26 outlook as defence demand rises but UK contract delays hit margins
Chemring Group’s record £1.4bn order book could not stop $CHG profit pressure. Find out what defence investors should watch next.
Debenhams Group returns to growth as $DEBS investors assess marketplace strategy and profit recovery
Debenhams Group returned to GMV growth in Q1 as $DEBS reaffirmed FY27 profit growth. Find out what the turnaround signal means.